A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-04
DOI
10.1038/srep13595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis
- (2013) Clemens Duerrschmid et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A new recombinant pituitary adenylate cyclase-activating peptide-derived peptide efficiently promotes glucose uptake and glucose-dependent insulin secretion
- (2012) Y. Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Tumor Necrosis Factor Receptors: Biology and Therapeutic Potential in Kidney Diseases
- (2012) Marijn M. Speeckaert et al. AMERICAN JOURNAL OF NEPHROLOGY
- Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
- (2012) Mouldy Sioud et al. BIOCHEMICAL PHARMACOLOGY
- Signal transduction by tumor necrosis factor receptors
- (2012) Lucía Cabal-Hierro et al. CELLULAR SIGNALLING
- Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD
- (2012) Ronghua Liu et al. JOURNAL OF CONTROLLED RELEASE
- Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
- (2012) Richard Gordon et al. Journal of Neuroinflammation
- Origin and evolution of TNF and TNF receptor superfamilies
- (2011) Gregory D. Wiens et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo
- (2011) Patric Lundberg et al. JOURNAL OF CONTROLLED RELEASE
- Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)
- (2010) H. W.M. van Laarhoven et al. CLINICAL CANCER RESEARCH
- Expression, identification and biological effects of a novel VPAC2-specific agonist with high stability and bioactivity
- (2009) Y. Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Thrombin physiology and pathophysiology
- (2009) Louis G. Licari et al. JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE
- Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor-Dependent Control of Glucose Homeostasis
- (2008) K. M. Picha et al. DIABETES
- Structure–Function Relationship of Tumor Necrosis Factor (TNF) and Its Receptor Interaction Based on 3D Structural Analysis of a Fully Active TNFR1-Selective TNF Mutant
- (2008) Yohei Mukai et al. JOURNAL OF MOLECULAR BIOLOGY
- Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
- (2008) Keren Borensztajn et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started